Patents by Inventor Darlene M. Dreon

Darlene M. Dreon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tocopherol enriched compositions and amelioration of inflammatory symptoms
    Patent number: 7119117
    Abstract: The present invention provides non-alpha-tocopherol enriched tocopherol compositions and non-alpha-tocopherol metabolite enriched compositions for use in the reduction of inflammatory markers associated with inflammation such as C-reactive protein.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: October 10, 2006
    Assignee: Galileo Pharmaceuticals, Inc.
    Inventors: Peggy Beinlich, Sekhar Boddupalli, Lesley A. Brown, Darlene M. Dreon, Stephen Flaim, Guy Miller, Stephen D. Phinney
  • Tocopherol enriched compositions for reducing IL6 levels
    Patent number: 7081476
    Abstract: Non-alpha-tocopherol enriched tocopherol compositions and non-alpha metabolite enriched compositions are disclosed for use in the reduction of the inflammatory marker IL-6.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: July 25, 2006
    Assignee: Galileo Pharmaceuticals, Inc.
    Inventors: Peggy Beinlich, Sekhar Boddupalli, Lesley A. Brown, Darlene M. Dreon, Stephen Flaim, Guy Miller, Stephen D. Phinney
  • Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
    Publication number: 20040048919
    Abstract: Medicaments and methods for the treatment and/or amelioration of certain inflammatory symptoms related to premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), perimenopause, menopause, endometriosis, post-partum depression, or administration of hormonal contraceptives are described herein. Medicaments of the invention comprise a tocopherol, an omega-3 polyunsaturated fatty acid, such as docosahexaenoic acid (DHA), or omega-9 polyunsaturated fatty acid, optionally, a flavonoid, and, optionally, a mineral, such as magnesium. Methods for treating or ameliorating such symptoms and methods for reducing elevated CRP and/or white blood cell (WBC) associated with such conditions using medicaments of the invention are also described.
    Type: Application
    Filed: July 2, 2003
    Publication date: March 11, 2004
    Inventors: Darlene M. Dreon, Stephen Dodge Phinney
  • Formulations and methods for treatment or amelioration of inflammatory conditions
    Publication number: 20030144219
    Abstract: Formulations and methods for the treatment and/or amelioration of symptoms of inflammatory conditions and associated systemic inflammatory responses are described herein. The compositions comprise a non-alpha tocopherol (especially gamma-, beta-, or delta-tocopherol) and one or more of an omega-3 fatty acid, such as docosahexaenoic acid (DHA) or a flavonoid.
    Type: Application
    Filed: November 15, 2002
    Publication date: July 31, 2003
    Inventors: Stephen Dodge Phinney, Darlene M. Dreon
  • Tocopherol enriched compositions and amelioration of inflammatory symptoms
    Publication number: 20030100603
    Abstract: The present invention provides non-alpha-tocopherol enriched tocopherol compositions and non-alpha-tocopherol metabolite enriched compositions for use in the reduction of inflammatory markers associated with inflammation and for use in the treatment and/or amelioration of symptoms of inflammation associated with for example, cardiovascular diseases or disorders, infectious diseases, diabetes, SIRS, asthma, neurodegenerative disorders, PMS; muscle fatigue or inflammation; and dermal conditions.
    Type: Application
    Filed: August 21, 2002
    Publication date: May 29, 2003
    Inventors: Peggy Beinlich, Sekhar Boddupalli, Lesley A. Brown, Darlene M. Dreon, Stephen Flaim, Guy Miller, Stephen D. Phinney